Posted in

Is 1-Hour Glucose Testing Essential for Women with PCOS?

Polycystic ovary syndrome affects millions of women across the globe. In India, physicians often struggle with identifying metabolic risks at an early stage. Therefore, researchers are now examining 1-hour plasma glucose PCOS levels for better clinical accuracy. Traditional testing usually focuses on fasting or two-hour results. However, these standard markers might not reveal early metabolic dysfunction in many patients. A recent retrospective study investigated this specific gap in clinical practice.

Consequently, scientists evaluated 1152 women who maintained normal sugar levels during traditional screenings. They discovered that one-hour glucose spikes provide critical health warnings. Specifically, women with higher levels faced greater metabolic dangers than their peers. Furthermore, these findings could change how doctors approach long-term care for PCOS patients.

Advantages of 1-hour plasma glucose PCOS Screening

The researchers identified 155 mg/dL as a vital threshold for risk assessment. Patients exceeding this limit showed significantly higher blood pressure readings. Additionally, these women had increased waist circumference and body mass index measurements. This group also exhibited worse lipid profiles, including higher triglyceride levels. Thus, the one-hour test reveals risks that standard two-hour tests often hide. Physicians should consider this marker for a more complete metabolic evaluation. By implementing this simple test, clinics can improve early intervention strategies for at-risk women.

Frequently Asked Questions

Q1: Why is the 1-hour glucose test beneficial for PCOS?

It identifies early cardiometabolic risks in women who pass traditional fasting and 2-hour glucose tests with normal results.

Q2: What glucose level indicates a higher risk in this study?

The study indicates that a level of 155 mg/dL or higher at the 1-hour mark suggests a significant increase in cardiometabolic risk factors.

References

  1. Jiang L et al. One-Hour Plasma Glucose and Early Cardiometabolic Risk in Normoglycaemic Women With Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study. BJOG. 2026 Mar 13. doi: 10.1111/1471-0528.70219. PMID: 41826069.
  2. Monash University. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023.
  3. Jagtap V, et al. Metabolic syndrome in polycystic ovary syndrome: A study from Western India. Indian J Endocrinol Metab. 2012;16(Suppl 2):S263-S266.